Nektar Therapeutics (NASDAQ:NKTR)

Delayed Data
As of 4:00pm ET
 +0.19 / +1.70%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 23.50, with a high estimate of 54.00 and a low estimate of 18.00. The median estimate represents a +106.32% increase from the last price of 11.39.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Hold stock in Nektar Therapeutics. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -15.49%
Growthannually -17.08%


Growthquarterly 35.53%
Growthannually -27.53%
Key to the earnings and sales forecast charts.